Shares rose after the Danish pharmaceutical giant Novo Nordisk launched Wegovy in the UK.
The maker of weight-loss drug Wegovy has become Europe's most valuable firm, dethroning the French luxury conglomerate LVMH.
Shares rose after the Danish pharmaceutical giant, Novo Nordisk, launched the popular drug in the UK.The drug is now available on the National Health Service in the UKWegovy is an obesity treatment that is taken once a week which tricks people into thinking that they are already full, so they end up eating less and losing weight., which has captivated Hollywood and the public more widely since it was approved by regulators in the US in 2021.
Wegovy and Ozempic - a diabetes treatment with similar effects - have been described as "miracle" drugs.In trials, users often put weight back on after stopping treatment.There has been a global shortage of the jabs so only limited stock arrived for the NHS in the UK on Monday.
"It's not common that you see a pharmaceutical company so entrenched in popular culture but there are people saying that we need to take a step back and ensure it is being used appropriately and responsibly. Of course, with a lot of fanfare for a drug, you are risking a lot of blowback in the future," she said.say patients can only access Wegovy, which contains the drug semaglutide, if they are significantly overweight and have weight-related health problems.
According to the Organisation for Economic Co-operation and Development , nearly one in three adults are obese in the UK, which is the highest level in Europe.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Weight-Loss Drug Wegovy Launches In U.K. As Shares Of Drugmaker Novo Nordisk Hit New PeakIn August, Novo Nordisk's CEO said it could “take quite some years” for the company to meet soaring demand for the popular drug.
Weiterlesen »
Novo Nordisk launches weight-loss drug Wegovy in UKNovo Nordisk launched its weight-loss injection Wegovy in Britain on Monday, its second debut in Europe in just over a month as the drugmaker seeks to expand in the region even as it struggles to keep up with soaring demand.
Weiterlesen »
Novo Nordisk's Wegovy weight loss drug launches in the UKNovo Nordisk launched its Wegovy weight loss injection in the U.K. Monday, furthering the drug’s rollout in Europe despite ongoing supply constraints.
Weiterlesen »
Wegovy makes UK weight-loss debut even as Novo struggles with supplies By ReutersWegovy makes UK weight-loss debut even as Novo struggles with supplies
Weiterlesen »
Weight-Loss Drugs Ozempic and Wegovy Can Also Protect the HeartA new study shows that semaglutide reduces heart failure symptoms like fatigue and swelling by bringing down body weight.
Weiterlesen »
Why is Wegovy weight-loss jab so hard to get access to?Soaring US demand and high drug prices may be keeping the weight loss injections from other nations
Weiterlesen »